Literature DB >> 1283809

Clinical, hematological, and molecular features in Sicilians with Hb S-beta-thalassemia.

G Schiliro1, P Samperi, R Testa, R B Gupta, L H Gu, T H Huisman.   

Abstract

The clinical, hematological, and molecular features of 81 patients with Hb S-beta-thalassemia and relatives from 76 unrelated families are reported. We analyzed the beta-thalassemia mutations and the beta S haplotypes in all patients and detected 6 different beta-thalassemia alleles: codon 39 (C-->T) (39 cases), IVS-I-1 (G-->A) (12 cases), IVS-II-1 (G-->A) (4 cases), IVS-I-6 (T-->C) (6 cases), IVS-I-110 (G-->A) (14 cases), and IVS-II-745 (G-->C) (6 cases). Eighty patients had haplotype #19 or the Benin type and one had haplotype #17 or the Cameroon type. The type of beta-thalassemia allele had the greatest influence on the phenotypic expression; this was observed for patients with Hb S-beta-thalassemia and for simple beta-thalassemia heterozygotes. The mild IVS-I-6 (T-->C) mutation produced borderline abnormal erythrocytic indices and Hb A2 levels in heterozygotes. Overall, there was a milder expression in beta(S) beta(+) patients (only 7.7% presented severe disease) than in those with the beta(S)beta(0) condition (22.6% had the severe form of the disease).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1283809     DOI: 10.1002/ajh.2830410408

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  3 in total

1.  Hemosiderosis causing liver cirrhosis in a patient with Hb S/beta thalassemia and no other known causes of hepatic disease.

Authors:  C Demosthenous; G Rizos; E Vlachaki; G Tzatzagou; M Gavra
Journal:  Hippokratia       Date:  2017 Jan-Mar       Impact factor: 0.471

2.  Sickle cell anemia, sickle cell beta-thalassemia, and thalassemia major in Albania: characterization of mutations.

Authors:  E Boletini; M Svobodova; V Divoky; E Baysal; M A Cürük; A J Dimovski; R Liang; A D Adekile; T H Huisman
Journal:  Hum Genet       Date:  1994-02       Impact factor: 4.132

3.  Clinical, hematologic and molecular variability of sickle cell-β thalassemia in western India.

Authors:  Malay B Mukherjee; Anita H Nadkarni; Ajit C Gorakshakar; Kanjaksha Ghosh; Dipika Mohanty; Roshan B Colah
Journal:  Indian J Hum Genet       Date:  2010-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.